MC-1-F2

Overview

MC-1-F2 is a FOXC2 inhibitor. MC-1-F2 shows a binding affinity ( K d ) of 26 μM for full-length FOXC2. MC-1-F2 reduces epithelial-mesenchymal transition ( EMT ) markers in breast cancer cells, suppresses cancer stem cell (CSC) properties and reduces invasiveness in castration-resistant prostate cancer (CRPC) cells. MC-1-F2 can be used for the study of CRPC and breast cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > FOXC | Products > Signaling Pathways > c-Myc | Products > Signaling Pathways > Cadherin

Product Information

• Catalog No.: HY-149894
• CAS No.: 2376894-10-7
• Molecular Formula: C37H46N16O2
• Molecular Weight: 746.87
• Purity: 99.69%
• Storage: 4°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
• Solubility: ≥ 2.5 mg/mL (3.35 mM); Clear solution
• Availability: In-stock

Source

Original product source